Option Witch | NIO's Q4 Losses Likely Widened, Will Cost Control Measures Lead to Profitability This Year?
$NIO(NIO)$ stock is drawing attention as the EV maker prepares to announce its fourth-quarter results before the U.S. market opens on Friday, Mar 21. So far, NIO stock has gained 12% this year.Three T
In every crypto bear cycle some big names get busted. MSTR may as well be the next one.
MicroStrategy: Shorts Are Playing With Fire
SummaryCitron Research is shorting MicroStrategy, but I believe the stock's bullish technicals make a sell rating unwarranted; I rate it a hold.Daily and weekly chart analyses show strong uptrends wit
I'm just curious, who on earth is taking COVID shots now?
EU Delays Approval of Novavax's Revised COVID Vaccine
European Union regulators have delayed the decision to give approval for Novavax's variant-tailored COVID-19 vaccine, the Financial Times said on Sunday.The European Medicines Agency , which was due to approve the updated vaccine last Friday has requested more information from the company, the FT report added."As part of the ongoing review process, [the EMA] has additional questions, which we are answering expeditiously," Novavax told the Financial Times.